tiprankstipranks
Invitae (NVTAQ)
OTHER OTC:NVTAQ
Holding NVTAQ?
Track your performance easily

Invitae (NVTAQ) Stock Forecast & Price Target

3,300 Followers
See the Price Targets and Ratings of:

NVTAQ Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Invitae
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NVTAQ Stock 12 Month Forecast

There Are No Analyst Ratings for NVTAQ In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

NVTAQ Financial Forecast

NVTAQ Earnings Forecast

Next quarter’s earnings estimate for NVTAQ is -$0.41 with a range of -$0.41 to -$0.41. The previous quarter’s EPS was ―. NVTAQ beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.10% of the time in the same period. In the last calendar year NVTAQ has Outperformed its overall industry.
Next quarter’s earnings estimate for NVTAQ is -$0.41 with a range of -$0.41 to -$0.41. The previous quarter’s EPS was ―. NVTAQ beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.10% of the time in the same period. In the last calendar year NVTAQ has Outperformed its overall industry.

NVTAQ Sales Forecast

Next quarter’s sales forecast for NVTAQ is $130.40M with a range of $130.40M to $130.40M. The previous quarter’s sales results were ―. NVTAQ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.01% of the time in the same period. In the last calendar year NVTAQ has Outperformed its overall industry.
Next quarter’s sales forecast for NVTAQ is $130.40M with a range of $130.40M to $130.40M. The previous quarter’s sales results were ―. NVTAQ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.01% of the time in the same period. In the last calendar year NVTAQ has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners
Hold
Reiterated
12/13/23
Leerink Partners Reaffirms Their Hold Rating on Invitae (NVTA)
Piper Sandler
$0.3
Sell
149900.00%
Upside
Assigned
11/13/23
Analysts' Opinions Are Mixed on These Healthcare Stocks: Invitae (NYSE: NVTA), Roivant Sciences (NASDAQ: ROIV) and Exact Sciences (NASDAQ: EXAS)
Morgan Stanley Analyst forecast on NVTAQ
Unknown Analyst
Not Ranked
Morgan Stanley
$4
Hold
1999900.00%
Upside
Reiterated
08/14/23

Best Analysts Covering Invitae

Which Analyst Should I Follow If I Want to Buy NVTAQ and Sell After:
1 Month
xxx
Success Rate
6/8 ratings generated profit
75%
Average Return
+6.08%
assigned a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +6.08% per trade.
3 Months
xxx
Success Rate
8/8 ratings generated profit
100%
Average Return
+38.55%
assigned a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +38.55% per trade.
1 Year
David WestenbergPiper Sandler
Success Rate
3/3 ratings generated profit
100%
Average Return
+58.23%
assigned a sell rating a year ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +58.23% per trade.
2 Years
No data currently available
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NVTAQ Analyst Recommendation Trends

Rating
Aug 23
Oct 23
Nov 23
Dec 23
Feb 24
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
3
1
3
3
5
Sell
7
4
5
4
2
Strong Sell
1
1
1
0
0
total
11
6
9
7
7
In the current month, NVTAQ has received 0 Buy Ratings, 5 Hold Ratings, and 2 Sell Ratings. NVTAQ average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NVTAQ Stock Forecast FAQ

What is NVTAQ’s average 12-month price target, according to analysts?
Currently, no data Available
What is NVTAQ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for NVTAQ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is NVTAQ a Buy, Sell or Hold?
      Currently, no data Available
      What is Invitae’s price target?
      Currently, no data Available
      What do analysts say about Invitae?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of NVTAQ?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis